Could this pill slow Alzheimer's? major trial underway
Disease control
Ongoing
This study tests whether a daily pill called buntanetap can improve thinking and daily living skills in people with early Alzheimer's disease. About 760 adults aged 55 to 85 will take either the drug or a placebo for 18 months. Researchers will measure changes in memory, problem-…
Phase: PHASE3 • Sponsor: Annovis Bio Inc. • Aim: Disease control
Last updated May 26, 2026 08:07 UTC